-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, MimlVpcqfHel7QNyE0pJlNXYCl/GD2sJzFyJq14URbHE/xkcsDS4RpdCkHpGBZ9r BBhq31yzbKms2lElSMo8MA== 0000914062-01-500093.txt : 20010223 0000914062-01-500093.hdr.sgml : 20010223 ACCESSION NUMBER: 0000914062-01-500093 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20010214 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: FIRST HORIZON PHARMACEUTICAL CORP CENTRAL INDEX KEY: 0001106773 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 582004779 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: SC 13G SEC ACT: SEC FILE NUMBER: 005-60977 FILM NUMBER: 1544399 BUSINESS ADDRESS: STREET 1: 660 HEMBREE PARKWAY STREET 2: SUITE 106 CITY: ROSWELL STATE: GA ZIP: 30076 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: KAPOOR JOHN N CENTRAL INDEX KEY: 0001033150 STANDARD INDUSTRIAL CLASSIFICATION: [] FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: 225 EAST DEERPATH RD STREET 2: SUITE 250 CITY: LAKE FOREST STATE: IL ZIP: 60045 BUSINESS PHONE: 7704429707 SC 13G 1 kap13g201.txt SCHEDULE 13G SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ---------------- SCHEDULE 13G INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13-d(1)(b)(c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) (AMENDMENT NO. ___________)1 First Horizon Pharmaceutical Corporation - -------------------------------------------------------------------------------- (Name of Issuer) Common Stock, $0.001 par value - -------------------------------------------------------------------------------- (Title and Class of Securities) 320 51K 106 - -------------------------------------------------------------------------------- (CUSIP Number) December 31, 2000 - -------------------------------------------------------------------------------- (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: Rule 13d-1(b) Rule 13d-1(c) |X| Rule 13d-1(d) - ---------------- 1 The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). Page 2 of 7 CUSIP NO. 320 51K 106 13G ----------- (l) Names of Reporting Persons I.R.S. Identification No. of Above Persons (Entities Only) John N. Kapoor, Ph.D. ________________________________________________________________________________ (2) Check the Appropriate Box if a Member of a Group (a) x . ------------------ (b) . ----------------- (3) SEC Use Only ________________________________________________________________________________ (4) Citizenship or Place of Organization United States ________________________________________________________________________________ Number of (5) Sole Voting Power 6,487,583 Shares Beneficially (6) Shared Voting Power 0 Owned by Each (7) Sole Dispositive Power 6,487,583 Reporting Person With (8) Shared Dispositive Power 0 ________________________________________________________________________________ (9) Aggregate Amount Beneficially Owned by Each Reporting Person 6,487,583 ________________________________________________________________________________ (10) Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares __________. ________________________________________________________________________________ (11) Percent of Class Represented by Amount in Row 9 50.0% ________________________________________________________________________________ (12) Type of Reporting Person IN ________________________________________________________________________________ Page 3 of 7 CUSIP NO. 320 51K 106 13G ----------- (l) Names of Reporting Persons I.R.S. Identification No. of Above Persons (Entities Only) Kapoor-Pharma Investments, L.P. ________________________________________________________________________________ (2) Check the Appropriate Box if a Member of a Group (a) x . ------------------ (b) . ------------------ ________________________________________________________________________________ (3) SEC Use Only ________________________________________________________________________________ (4) Citizenship or Place of Organization Delaware ________________________________________________________________________________ Number of (5) Sole Voting Power 6,487,583 Shares Beneficially (6) Shared Voting Power 0 Owned by Each (7) Sole Dispositive Power 6,487,583 Reporting Person With (8) Shared Dispositive Power 0 (9) Aggregate Amount Beneficially Owned by Each Reporting Person 6,487,583 ________________________________________________________________________________ (10) Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares __________. ________________________________________________________________________________ (11) Percent of Class Represented by Amount in Row 9 50.0% ________________________________________________________________________________ (12) Type of Reporting Person PN ________________________________________________________________________________ Page 4 of 7 Item l(a). Name of Issuer: First Horizon Pharmaceutical Corporation Item l(b). Address of Issuer's Principal Executive Offices: 660 Hembree Parkway, Suite 106 Roswell, GA 30076 Item 2(a). Name of Person Filing: See item (l) of the cover pages Item 2(b). Address of Principal Business Office: The principal business office for both reporting persons is 225 East Deerpath, Suite 250, Lake Forest, IL 60045 Item 2(c). Citizenship: See item (4) of cover pages Item 2(d). Title of Class of Securities: Common Stock, $0.001 Par Value Item 2(e). CUSIP Number: 320 51K 106 Item 3. If this statement is filed pursuant to Rule 13-d(1)(b) or 13d-2(b) or (c), check whether the person filing is a: Not applicable Item 4. Ownership. John N. Kapoor is the President and sole stockholder of EJ Financial Enterprises, Inc. which is the managing general partner of Kapoor - Pharma Investments, L.P. As such, the ownership interest of both John N. Kapoor and Kapoor-Pharma Investments, L.P. is as follows: (a) Amount beneficially owned: See item (9) of cover pages Page 5 of 7 (b) Percent of Class: See item (11) of cover pages (c) Number of shares as to which such person has: (i) sole power to vote or to direct the vote: See item (5) of cover pages (ii) shared power to vote or to direct the vote: See item (6) of cover pages (iii) sole power to dispose or to direct the disposition of: See item (7) of cover pages (iv) shared power to dispose or to direct the disposition of: See item (8) of cover pages Item 5. Ownership of Five Percent or Less of a Class: Not applicable. Item 6. Ownership of More than Five Percent on Behalf of Another Person: Kapoor-Pharma Investments L.P. is a limited partnership organized under the laws of Delaware. EJ Financial Enterprises, Inc. is the managing general partner of Kapoor-Pharma Investments and owns a .801% general partnership interest. John Kapoor is the sole stockholder of EJ Financial Enterprises. The limited partnership interests of Kapoor-Pharma Investments, L.P. are owned by various family trusts and by Kamal Kapoor, John Kapoor's brother. The limited partnership interests of Kapoor-Pharma Investments, L.P. are held as follows: The John N. Kapoor Trust dated September 20, 1989 owns 52.206%, the John N. Kapoor 1999 Descendants Trust owns 13.342%, the Bob Kapoor Discretionary Trust owns 26.797%, Kamal Kapoor owns 6.709%, The Jules Alexander Kapoor Trust dated December 1990 owns .237%, The Olivia Jane Kapoor Trust dated December 1990 owns .237%, The Jonathan Nath Kapoor Trust dated December 1990 owns .237% and The Christina Grace Kapoor Trust dated December 1990 owns .237%. Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person: Not applicable Item 8. Identification and Classification of Members of the Group: Page 6 of 7 The members of the group filing this Schedule 13G are John N. Kapoor and Kapoor-Pharma Investments, L.P. Item 9. Notice of Dissolution of Group: Not applicable Item 10. Certification: Not applicable Page 7 of 7 SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. February 14, 2001 __________________________________________________ (Date) /s/ John N. Kapoor, Ph.D. ___________________________________________________ (Signature) John N. Kapoor, Ph.D. __________________________________________________ (Name/Title) February 14, 2001 __________________________________________________ (Date) /s/ John N. Kapoor, Ph.D. __________________________________________________ (Signature) John N. Kapoor, Ph.D., President, EJ Financial Enterprises, Inc., as Managing General Partner of Kapoor-Pharma Investments, L.P. __________________________________________________ (Name/Title) 1324244 -----END PRIVACY-ENHANCED MESSAGE-----